PAR Ann: Phase 3 OA Trial to Proceed after Formal Safety Review - 28th Dec 2022, 12:06pm

annb0t

annb0t

Top 20
PAR Ann: Phase 3 OA Trial to Proceed after Formal Safety Review
Price Sensitive: Y
Date: 28th Dec 2022, 12:06pm

>>> Read announcement: Google: PAR Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
PAR Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial - 18th Oct 2023, 9:18am
Replies
0
Views
76
annb0t
annb0t
annb0t
PAR Ann: PAR Reports Phase 3 Clinical Trial Update - 4th Jul 2023, 8:19am
Replies
0
Views
144
annb0t
annb0t
annb0t
PAR Ann: PAR Phase 2 MPS VI clinical trial completes enrolment - 28th Apr 2023, 9:53am
Replies
0
Views
73
annb0t
annb0t
annb0t
PAR Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study - 4th Apr 2023, 9:29am
Replies
0
Views
107
annb0t
annb0t
annb0t
PAR Ann: Paradigm Doses First UK Participant in Phase 3 Trial - 26th Oct 2022, 9:35am
Replies
0
Views
164
annb0t
annb0t
Top Bottom